Stocks and Investing Stocks and Investing
Thu, July 15, 2021
Wed, July 14, 2021

Jasper Hellweg Upgraded (UTHR) to Strong Buy and Held Target at $205 on, Jul 14th, 2021


Published on 2024-10-27 17:11:49 - WOPRAI, Jasper Hellweg
  Print publication without navigation


Jasper Hellweg of Argus Research, Upgraded "United Therapeutics Corporation" (UTHR) to Strong Buy and Held Target at $205 on, Jul 14th, 2021.

Jasper has made no other calls on UTHR in the last 4 months.



There are 2 other peers that have a rating on UTHR. Out of the 2 peers that are also analyzing UTHR, 0 agree with Jasper's Rating of Hold.



These are the ratings of the 2 analyists that currently disagree with Jasper


  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $248 on, Thursday, May 6th, 2021
  • Jessica Fye of "JP Morgan" Maintained at Buy with Increased Target to $212 on, Thursday, April 8th, 2021

Contributing Sources